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Thehealingactivitiesofblacktea(BT)andthetheaﬂavins(TF)againsttheindomethacin-inducedstomachulcerationwerestudied
in a mouse model. Indomethacin (18mg/kg, p.o.) administration induced maximum ulceration in the glandular portion of the
gastric mucosa on the 3rd day, accompanied by increased lipid peroxidation and protein oxidation, depletion of thiol-defense and
mucin, as well as reduced expressions of cyclooxygenases (COX) and prostaglandin (PG) E synthesis in the gastric tissues, and
plasma total antioxidant status of mice. Treatment with BT (40mg/kg), TF (1mg/kg), and omeprazole (3mg/kg) produced similar
(74%–76%)ulcerhealing,asrevealedfromthehistopathologicalstudies.Treatmentwithalltheabovesamplesreversedtheadverse
oxidative eﬀects of indomethacin signiﬁcantly. BT and TF also enhanced the PGE synthesis by augmenting the expressions of COX
1 and 2, but did not modulate acid secretion.
1.Introduction
Stomach ulceration induced by nonsteroidal anti-
inﬂammatory drugs (NSAIDs) is a major medical problem,
ranking fourth in terms of causing morbidity and mortality
[1]. The NSAID-related gastroduodenal damage is very
frequent, and the most serious complication of any drug
therapy. The NSAIDs mainly cause upper gastrointestinal
(GI) complications, ranging from dyspeptic symptoms in
up to 40%, to peptic ulceration in 20–30% of the chronic
NSAID users, and even duodenal ulcers. Currently, the use
of NSAIDs accounts for approximately 25% of gastric ulcer
cases [2, 3]. The commercially available synthetic antiulcer
drugs show side eﬀects [4] and cannot prevent ulcer
recurrence. Hence, there is a need to develop alternative
herbal formulations. For centuries traditional medical
systems are being used to treat various diseases in the
countries of their origin. Despite the present dominance of
the scientiﬁcally proven therapies, there is a renewed public
interest in complementary and alternative medicines even in
the Western world [5, 6]. This has been prompted, in part,
by increased side eﬀects and high cost of new drugs, lack
of curative treatment for several chronic diseases, microbial
resistance, and emerging diseases.
Several plants and herbs are used in traditional medicine
to treat GI disorders. Documented scientiﬁc studies have
demonstrated that many of these medicinal plants and their
constituent phytoceuticals not only provide gastroprotection
against various ulcerogens, but also accelerate ulcer healing
[7, 8]. Many taxa of medicinal plants have been assessed
worldwide for their antiulcerogenic eﬀects [9, 10]. The
traditional Japanese medicine, Rikkunshito, is used in Japan
totreatvariousGIdisorders,whiletheunripefruitsofCarica
papaya, extensively used in India for stomach problems, has
been suggested to be beneﬁcial in gastric ulcer [11, 12].
Besides the use of NSAIDs, Helicobacter pylori infection is
perhaps the most signiﬁcant cause for gastric ulceration,
leading to even gastric cancer. Diﬀerent alternative and2 Evidence-Based Complementary and Alternative Medicine
traditional medicines are being critically analyzed for their
eﬃcacyvis-` a-visthecurrentlyusedtripletherapytoeradicate
the bacteria [13, 14].
For decades, doctors have recommended dietary adjust-
ments aimed at preventing or treating symptoms of gastritis
and ulceration, as diet may moderate the risk for gastritis or
peptic ulcer [15]. Camellia sinenesis is widely grown in the
tropical humid climate of South East Asia, and decoction of
its leaves (tea) is the most popular nonalcoholic beverage
worldwide. Tea is consumed in three basic forms: green
tea, black tea, and oolong tea. Extensive work has been
carried out regarding various medicinal attributes of green
tea. Of these, its protective capacity against cancer [16]a n d
cardiovascular disease [17] are of contemporary signiﬁcance.
The cytoprotective action of the green tea catechins against
ethanol- or restraint plus water-immersion stress-induced
acute gastric mucosal injury and acetic acid-induced chronic
gastric ulcers in rats has been reported [18]. In addition,
epigallocatechin gallate, a constituent of green tea, has been
suggested to control H. pylori-related chronic inﬂammations
or regress cancer precursor lesions, while a pectin-type
acidic polysaccharide from green tea is reported to posses
antiadhesive eﬀects against H. pylori [19]. It is believed that
polyphenols or polyphenol derivatives from green tea may
be useful in either the prevention or the treatment of H.
pylori-associated gastric diseases. Many of the health beneﬁts
of green tea are attributed to its antioxidant property [20].
Although black tea (BT) accounts for 80% of the total tea
consumption, studies on the pharmacological properties of
BTarescarce.Theprophylacticactionoftheteaseed-derived
triterpene saponins against ethanol-induced gastric mucosal
lesions [21, 22] and of BT extract against various ulcerogens
[23, 24]h a v eb e e nr e p o r t e di nr a tm o d e l s .T h eF o o da n d
Agricultural Organisation (FAO) of the United Nations has
stressed the need for research on the health beneﬁts of BT in
its totality, and not on certain isolated fractions/constituents
[25].Intherecentyearstherehasbeenamountinginterestin
exploring the possibility of using BT as a supplement among
patients.
The tea polyphenols, especially the catechins are primar-
ily responsible for the curing property of green tea [26].
However, during the production of BT, a signiﬁcant part
of the catechins is converted to the theaﬂavins (comprising
of theaﬂavin-3-gallate, theaﬂavin-3 -gallate, and theaﬂavin-
3,3 -digallate) and thearubigins by a polyphenol oxidase
[27]. Hence, one of the aims of the present study was to
evaluatethehealingpropertyofBTanditsmajorconstituent,
the theaﬂavins (TF) vis-` a-vis that of omeprazole (Omez)
against indomethacin-induced acute gastric ulceration in
mice. Given the complexity of the ulcer healing process, the
reported [24] cytoprotective property of BT against stomach
ulceration does not guarantee its healing potency. Factors
such as oxidative stress and reduced PG synthesis contribute
to the NSAID-induced gastropathy. Hence the role of BT
and TF in modulating these biochemical parameters was
also investigated. Our results revealed that the biochemical
transformation of green tea into BT did not hamper the
ulcer healing property, and also established TF as the active
antiulcerogenic principle of BT. Both BT and TF were found
to exert their action by augmenting mucosal antioxidant
defense, protecting mucin and increasing the cyclooxygenase
(COX-) derived prostaglandin E (PGE) synthesis.
2. Methods
2.1. Chemicals and Reagents. Leaves of C. sinenesis (Brooke
Bond, Red label) procured from the local market were
identiﬁed by hptlc and hplc analyses of its chemical con-
stituents. Alcian blue, indomethacin, bovine serum albumin
(BSA), haematoxylene, alum, eosin, butylated hydroxy-
toluene(BHT),guanidinehydrochloride,triﬂuoroaceticacid
(TFA), omeprazole (Omez), TF, and sucrose were procured
from Sigma, St. Louis, MO. Other reagents used were 2-
thiobarbituric acid (TBA), ethanol, butanol and ethyl acetate
(E. Merck, Mumbai, India), trichloroacetic acid (TCA,
Thomas Baker, Mumbai, India), hydrogen peroxide (35%,
Lancaster, Morecambe, UK), 2,4-dinitrophenyl hydrazine
(DNPH), disodium hydrogen phosphate and sodium dihy-
drogen phosphate (BDH, Mumbai, India), antibodies for
COX-1 and COX-2 (Santa Cruz Biotechnology, Santacruz,
CA), Lumi-Light
PLUS western blotting kit (Roche Applied
Science, Baden-Wurttemberg, Mannheim), nitrocellulose
membrane (BioTraceNT) (Pall Life Sciences, Easthills, NY),
β-actin antibody (Cell Signaling Technology Inc., Danvers,
MA), and PGE metabolite EIA kit (Cayman Chemical, Ann
Arbor, MI).
2.2. Preparation of BT Extract. Tea leaves (30 g) were soaked
in preheated (102◦C) distilled water (100mL), allowed to
stand for 5min, and the supernatant decanted. The process
was repeated two times and the combined aqueous extracts
were lyophilized to get BT as a sticky dark brown solid.
2.3. Chemical Composition of BT
2.3.1. Total Phenolics and Flavonoids Contents (TPC and
TFC). Following a known method [28] the amounts of total
phenolics in BT was determined. Gallic acid monohydrate
was used as the standard and the TPC is expressed as mg
gallic acid equivalent (GAE)/g of BT.
The known method [29] downscaled to 1mL was
followed to estimate TFC. To a solution of BT (100μg) in
0.4mL distilled water at 25◦Cw a sa d d e dN a N O 2 (0.03mL,
5%), followed by AlCl3 · 6H2O (0.03mL, 10%), after 5min.
Afterincubatingfor6min,aqueousNaOH(0.2mL,1M)was
added, and the mixture was diluted to 1mL with water. The
TFC was estimated from the absorbance of the mixture at
510nm, using epicatechin as the standard. The TFC value is
expressed as mg epicatechin equivalent (ECE)/g of BT.
2.3.2. Chromatographic Characterization. BT (0.372g) was
successively extracted with ethyl acetate and butanol (each
5mL, 3 times). The individual extracts were concentrated
in vacuo, and the butanol-soluble fraction was analyzed by
HPTLC (Camag Instrument, RP-18 silica gel G plate, ethyl
acetate:methanol:water=10:1.1:1 as the solvent). The
major chemical constituents were identiﬁed by comparingEvidence-Based Complementary and Alternative Medicine 3
the retention times of the commercially available authentic
compounds, under identical conditions. For quantiﬁcation,
standard graphs of the authentic samples were used.
2.4. Ulcer Healing Activity
2.4.1. Test Samples Preparation. For the ulcer-healing exper-
iments, the test samples (BT, TF, and Omez) were prepared
as aqueous suspensions in 2% gum acacia as the vehicle, and
administered to the mice orally.
2.4.2. Animals. Male Swiss albino mice, bred at BARC Labo-
ratory Animal House Facility, Mumbai, India, were procured
after obtaining clearance from the BARC Animal Ethics
Committee (BAEC). All the experiments were conducted
with strict adherence to the ethical guidelines laid down
by European Convention for the Protection of Vertebrate
Animals used for Experimental and Other Scientiﬁc Pur-
poses. In addition, the ethical guidelines, laid down by the
Committee for the Purpose of Control and Supervision
of Experiments on Animals (CPCSEA), constituted by the
Animal Welfare Division, Government of India, on the use
of animals in scientiﬁc research were followed. The mice (6–
8 weeks old, 25–30g) were reared on a balanced laboratory
diet as per National Institute of Nutrition, Hyderabad, India,
and given tap water ad libitum. They were kept at 20±2◦C,
65%–70% humidity, and 12h day/12h night cycles. The
experiments were performed by two investigators blinded to
the group and treatment of animals, which were identiﬁed
by typical notches in the ear and limbs (performed at a
preweaning stage to minimize the pain to the animals), and
then randomized.
2.4.3.UlcerationProtocol. Themiceweredividedintoseveral
groups (each containing ﬁve mice), and each experiment
was repeated three times. Except for the normal control,
ulceration in the other mice was induced by indomethacin
(18mg/kg, p. o., single dose), dissolved in distilled water
and suspended in 2% gum acacia as the vehicle. For the
standardization ofdoses, BT(10–50mg/kg,p. o.)orTF(0.5–
5.0mg/kg, p. o.) were given to the mice once daily up to
7 days, starting the ﬁrst dose 6h after the indomethacin-
administration.Inthesubsequentdays,thetestsampleswere
given at 9 AM on each day. Omez (3.0mg/kg, p. o.) was
used as the positive control. The doses of indomethacin
and Omez were standardized in our earlier study [30]. The
normal and ulcerated control groups of mice were given
the vehicle (0.2mL) during the entire period of study. Four
hours after the last dose of the test samples, the mice were
sacriﬁced on the 3rd, 5th, and 7th days under anesthesia
with thiopental, the stomachs were opened along the greater
curvature, thoroughly rinsed with normal saline, and the wet
weights of the tissues were recorded.
2.4.4. Ulcer Healing Assessment. T h eg a s t r i cm u c o s a la r e a s
were visualized using a transparent sheet and a dissecting
microscope. The extent of healing was assessed from the
MDS of the untreated and treated mice. The gastric injury
(MDS) was scored [31] by grading on a 0–4 scale, based
on the severity of hyperemia and hemorrhagic erosions:
0—almost normal mucosa, 0.5—hyperemia, 1—one or two
lesions, 2—severe lesions, 3—very severe lesions, 4—mucosa
full of lesions (lesions—hemorrhagic erosions, hyperemia—
vascular congestions). The macroscopic data are presented
as mean±S.E.M. from the review of a minimum of three
sections per animal and ﬁve animals per group.
Forhistopathology,theulceratedportionsofthestomach
were ﬁxed in 10% formol saline solution for 24h, embedded
in paraﬃn blocks, and cut into 5μm sections. These were
placed onto glass slides, stained with haematoxylene and
eosin, and viewed under a light microscope. Histological
sections were coded to eliminate an observer bias.
2.5. Biochemical Analyses. The MDS results revealed peak
ulceration, and also maximum ulcer healing by the test
samples on the 3rd day after indomethacin administration.
Hence, we assessed the biochemical parameters on the
3rd day of ulceration under the optimized doses of the
test samples (BT (40mg/kg), TF (1mg/kg), and Omez
(3mg/kg)). For this, the mice were equally divided into ﬁve
groups as follows.
Group I—normal mice; Group II—ulcerated mice;
Groups III-V—ulcerated mice, treated with BT, TF, and
Omez, respectively. The total antioxidant status (TAS)
was measured using plasma, while PGE was determined
using both serum and tissue lysate. The other biochemical
parameters were analyzed using the ulcerated portions of the
glandular stomach tissues of the mice.
2.5.1. TAS Assay. Following a reported method [32]a n d
manufacturer’s instructions, the TAS of plasma (mmol/L)
was measured using a Randox kit. Brieﬂy, plasma (20μL)
or the standard (6-hydroxy-2,5,7,8-tetramethylchroman-
2-carboxylic acid, 1.65mmol/L) or reagent blank (double-
deionized H2O) were mixed with 1mL chromogen
(metmyoglobin, 6.1μmol/L and 2,2 -azino-di[3-ethylbenz-
thiazoline] sulphonate, 610μmol/l). After mixing, the
initial absorbance (A1) at 600nm was read at 37◦C.
Hydrogen peroxide (200μL, 250μM) was added to the
sample/standard/blank, and the absorbance (A2) was read
exactly after 3min. Subtraction of the respective A2 values
from A1 gave the absorbance of sample/standard/blank.
The respective TAS was obtained using the formulae:
TAS =factor×(absorbance of blank−absorbance of sam-
ple)mmol/L; factor=concentration of standard/(absorb-
ance of blank−absorbance of standard).
2.5.2. Protein and Lipid Damages Assay. The glandular
stomachtissuesfromﬁveanimalsofeachgroupwerepooled,
rinsedwithphosphatebuﬀer(50mM,pH7.4),homogenized
in the same buﬀer with a glass-Teﬂon homogenizing tube,
and centrifuged at 1200×g to obtain the supernatant. The
amount of protein carbonyls was determined using a known
method [33]. Brieﬂy, DNPH (4mL, 10mM) in 2M HCl was
added to the supernatant (1.0mL), which was incubated for
1h with intermittent shaking. Ice-cold 20% aqueous TCA4 Evidence-Based Complementary and Alternative Medicine
solution (5mL) was added and the mixture incubated for
15min.Theprecipitatedproteinwaswashedthreetimeswith
a mixture of ethanol-ethyl acetate (1:1), and subsequently
dissolved in a solution (1mL) containing 6M guanidine
HCl in 20mM potassium monobasic phosphate, adjusted
to pH 2.3 with TFA. After centrifuging, the amount of
protein carbonyl was determined from the absorbance of the
supernatant at 362nm ( = 2.2 ×104M
−1cm−1).
For the analysis of lipid peroxidation (measured in terms
of thiobarbituric acid reactive species (TBARS)), a 10%
homogenateoftheglandularstomachtissueswaspreparedin
ab u ﬀer containing (320mM sucrose, 5mM HEPES, 20mM
EDTA, and 0.01% BHT). The samples were centrifuged at
1200×g for 15min, and the supernatant centrifuged again
at 12000×g for 30min to obtain the mitochondrial pellets.
These were washed with a buﬀer (150mM KCl and 20mM
phosphate buﬀer) and ﬁnally suspended in a phosphate
buﬀer (50mM, pH 7.4). The mitochondrial membrane
fraction (1mL) was treated with TCA/TBA/HCl (2mL, 15%
TCA, 0.375% TBA, 0.25N HCl) containing 0.01% BHT,
heated on a boiling water bath for 15min, cooled, and
centrifugedat3000×gfor5min.TheamountofTBARSwas
calculated from the absorbance of the supernatant at 535nm
( = 1.56 ×105M
−1cm−1).
2.5.3. Nonprotein Thiol (NP-TSH) Assay. Following a
reported method [34], the gastric mucosal NP-TSH was
measured. Brieﬂy, the glandular stomach homogenates were
prepared in 0.2 M Tris-HCl buﬀer, pH 8.2 containing
20mM EDTA and centrifuged at 1200×g for 15min. An
aliquot of the homogenate (1mL) was treated with ice-
cold 20% TCA (1mL), centrifuged at 3000×g for 5min,
and the supernatant (1mL) was added to Tris-HCl buﬀer
(2mL, 0.8M, pH 9) containing 20mM EDTA, and mixed
with DTNB (0.1mL, 10mM). The NP-TSH content was
calculated from the absorbance of the chromogen at 412nm
( = 13.6 ×104M
−1cm−1).
2.5.4. Mucin Assay. F o l l o w i n gar e p o r t e dm e t h o d[ 35], the
free mucin content in the gastric tissues was estimated by
measuring the amount of alcian blue bound to mucus.
Brieﬂy, the glandular stomach tissues were incubated with a
1%buﬀeredsucrosesolutionofalcianbluein(0.1%)sodium
acetate at 37◦C for 60min. After incubation, the tissues were
washed with sucrose and centrifuged. The supernatant was
extracted with MgCl2, and the amount of alcian blue was
estimated spectrophotometrically at 610nm. The quantity
(μg) of alcian blue/g of wet glandular tissue was calculated.
2.5.5. Western Blots. Equal amounts of glandular stom-
a c ht i s s u el y s a t e s( 8 0 μg) were separated by 12% SDS-
polyacrylamide gel electrophoresis, and electrotransferred
to nitrocellulose membrane. The membranes were blocked
f o r1ha tr o o mt e m p e r a t u r ei nT B S Tb u ﬀer (10mM Tris-
HCl, pH 8.0, 150mM NaCl, and 0.1% Tween-20) containing
5% (w/v) nonfat milk, and incubated overnight at 4◦C
with appropriate primary antibodies (1:3000). After several
washes, HRP-conjugated secondary antibody (1: 5000) was
added, the membranes were incubated further for 1h, and
the blots were developed using a Lumi-Light
PLUS western
blottingkit.Thebandswerequantiﬁedwithrespecttothatof
β-actin bands, using a Kodak Gelquant software. The values
(arbitrary unit, mean±S.E.M.) are the density scanning
resultsof threeindependent experiments, considering thatof
normal mice as 1.
2.5.6. PGE Assay. Following harvesting of the stomach, the
corpus (full thickness) was excised, weighed (∼100mg), and
homogenized in 10mM sodium phosphate buﬀer, pH 7.4
(1mL). After centrifugation (9000×g), the PGE level in the
supernatant was measured by ELISA, and the concentration
is expressed as pg/mg protein. The PGE level in the sera was
also measured similarly and the value is expressed as pg/mL.
2.6. Statistical Analysis. T h ed a t aa r ep r e s e n t e da sm e a n ±
S.E.M. The biochemical data were analyzed using a paired
“t” test for the paired data or one way analysis of variance
(ANOVA) followed by a Dunnet multiple comparisons
post test. Nonparametric data (MDS) were analyzed using
Kruskal-Wallis test (nonparametric ANOVA) followed by a
Dunn’s multiple comparisons post test. A probability value
of P<0.05 was considered signiﬁcant.
3. Results
3.1. Chemical Analysis of BT. T h ee t h y la c e t a t ee x t r a c to f
BT provided a negligible amount of the residue, while
the butanol extract furnished a fraction in 0.73% yield.
The HPTLC analyses of this fraction revealed caﬀeine (Rf
0.39) as its major (70%) component along with the TFs
(∼18%, Rfs 0.04, 0.08, and 0.11). In addition, the fraction
also contained epigallocatechin (Rf 0.18, 1.8%), catechin (Rf
0.20, 2.9%), and epicatechin (Rf 0.25, 5.5%), along with
two less polar unidentiﬁed compounds (Rfs 0.47 and 0.63)
in traces. The components were identiﬁed by comparison
with commercially available authentic samples. This was also
conﬁrmedbytheHPLCanalysis.TheTPCandTFCvaluesof
BT were 222.03±6.31mg GAE/g of BT and 77.95±4.17mg
ECE/g of BT, respectively.
3.2. Both BT and TF Heal Indomethacin-Induced
Gastric Ulcers in Mice
3.2.1. Dose Standardization. The doses of the test samples
for eﬀective ulcer healing were optimized by carrying out
the treatment with diﬀerent doses of BT (10–50mg/kg)
and TF (0.5–5.0mg/kg) up to seven days, and the results
are presented in Table 1. Omez was used as the positive
control. The mice receiving only vehicle showed no mucosal
lesions. Indomethacin (18mg/kg) administration produced
acute lesions in the gastric mucosa of the mice, measured in
terms of MDS. Treatment with the test samples for 3 days
accelerated the healing of gastric lesion dose-dependently.
Overall, treatment with BT (40mg/kg) and TF (1.0mg/kg)
for 3 days after ulcer induction provided optimal and
comparable (74.1% and 76.4%, resp.) ulcer healing, whichEvidence-Based Complementary and Alternative Medicine 5
20
30
40
50
60
70
80
90
100
110
01 0 2 0 3 0 4 0
M
a
c
r
o
s
c
o
p
i
c
d
a
m
a
g
e
s
c
o
r
e
Dose of BT(mg/kg)
(a)
20
40
60
80
100
00 .511 .522 .5
M
a
c
r
o
s
c
o
p
i
c
d
a
m
a
g
e
s
c
o
r
e
Dose of TF(mg/kg)
(b)
Figure 1: Concentration-dependent healing capacities of (a) BT and (b) TF on the 3rd day after indomethacin-induced stomach ulceration
in mice. Ulceration in the mice was induced by indomethacin (18mg/kg, p. o.). The healing capacity was calculated from macroscopic
damage scores (MDS), measured 4h after the last dose of the test samples. The MDS in ulcerated untreated mice was taken as 100. The
values are mean±S.E.M of three independent experiments, each with 5mice/group. The IC50 values (concentration that produces 50%
ulcer healing) of BT and TF (determined by Probit analysis) were signiﬁcantly diﬀerent (P<0.01).
Normal Ulcerated
BT-treated TF-treated Omez-treated
Figure 2: Histological assessment of acute gastric mucosal injury induced by indomethacin (18mg/kg, p. o.) in mice and its prevention by
BT (40mg/kg), TF (1mg/kg), and Omez (3.0mg/kg). The section of mice stomachs were dissected 4h after the last dose of the respective
test samples on the 3rd day of ulceration. Black arrows indicate mucosal damage.
did not improve much even at their respective highest
doses.The3day-treatmentwithOmez(3.0mg/kg)produced
74.7% ulcer healing. Extending the treatment up to seven
days with the respective optimized doses of BT and TF led
to only marginally better healing than that observed with the
three-day treatment regime. However, a major part of this
was due to natural healing, with less contribution by the test
samples. Hence, all subsequent experiments were carried out
with the optimized dose of the test samples. Considering the
MDSvaluesofthe3rdday-ulcerateduntreatedmiceas100%,
the IC50 values of BT and TF were found to be 24.5±2.79
and 0.38±0.05mg/kg, respectively, (Figures 1(a) and 1(b)).6 Evidence-Based Complementary and Alternative Medicine
Table 1: Dose and day-dependent healing capacities of BT and TF against indomethacin-induced stomach ulceration in mice
a.
Group Drug dose (mg/kg) Period of treatment (days) Macroscopic damage scores (MDS)
b MDS reduction (%)
c
3rd day-ulcerated untreated — 3.39 ±0.24 0
5th day-ulcerated untreated 1.21 ±0.15
7th day-ulcerated untreated 0.68 ±0.07
BT-treated 10 3 2.64 ±0.22
∗ 22.13
BT-treated 20 3 1.89 ±0.17
∗∗ 44.25
BT-treated 30 3 1.47 ±0.15
† 56.64
BT-treated 40 3 0.88 ±0.06
†,# 74.05
BT-treated 50 3 0.83 ±0.07
†,# 75.52
BT-treated 40 7 0.55 ±0.12 83.78
TF-treated 0.5 3 1.12 ±0.13
† 66.96
TF-treated 1 3 0.81 ±0.07
†,Ψ 76.4
TF-treated 2.5 3 0.74 ±0.06
†,Ψ 78.17
TF-treated 4 3 0.62 ±0.07
†,Ψ 82.3
TF-treated 5 3 0.53 ±0.06
†,Ψ 84.36
TF-treated 1 7 0.46 ±0.08 86.44
aStomach ulceration in mice was induced by oral administration of indomethacin (18mg/kg). Diﬀerent doses of BT and TF were used for these experiments.
bTheMDSweremeasuredonthe3rd,5th,and7thdayafterindomethacinadministrationandthevaluesaremean±S.E.Mofthreeindependentexperiments,
each with 5mice/group. cConsidering a MDS value of 100 for the 3rd day untreated mice. ∗P < 0.05, ∗∗P < 0.01, †P < 0.001 compared to ulcerated mice;
#P < 0.05 compared to BT (30mg/kg) treatment; ΨP < 0.05 compared to TF (0.5mg/kg) treatment.
3.2.2.HistologicalAssessment. Within6hafterindomethacin
administration, superﬁcial erosion and mild inﬂammation
in the stomach were observed, indicating acute ulceration
(ﬁgure not shown). However, on the 3rd day, marked
damage to the glandular portion of the gastric mucosa
was noticed in the histological photograph of the stomach
sections of the 3rd day-ulcerated group of mice. Multiple
punched-out areas of ulceration with inﬂammatory inﬁltrate
containing neutrophils and macrophages in the mucosa,
along with haemorrhagic serosa were evident on the 3rd
day of ulceration. Treatment with BT, TF, and Omez for 3
days reduced the number of inﬂammatory cells and mucosal
congestion,andincreasedthenumberofhealthynormalcells
in the gastric mucosa, submucosa, serosa, and muscle layers.
Mucosal hyperplasia along with cryptic proliferation with no
frank denudation was the major hallmark of the treatment.
The eﬀect of TF was slightly better amongst the test samples.
The histological photographs of stomach sections of the 3rd
day-groups of normal, ulcerated, and treated mice are shown
in Figure 2.
3.3. BT and TF Alters Various Gastrointestinal
Biochemical Parameters
3.3.1. BT and TF Reduce the Oxidative Stress, Caused by
Gastric Ulceration. Indomethacin administration markedly
stimulated lipid peroxidation in gastric tissues, and the
TBARS content was elevated by 132.6% on 3rd day, com-
pared to the normal value. BT and TF reduced it by 45.8%
and 49.1%, respectively, compared to the group II mice. The
eﬀect of Omez (38.8%) was less than that of BT and TF.
Compared to the normal value, the protein carbonyl content
of the ulcerated mice was increased (154%) on the 3rd day
of ulceration. BT and TF reduced it by 49.5% and 53%,
respectively, while Omez reduced it by 39.4%, compared to
the group II mice. Likewise, ulceration decreased (12.8%)
NP-TSH, compared to the normal value. All the test samples
increased it signiﬁcantly, compared to that of the ulcerated
mice. The results are presented in Figure 3.
The plasma TAS level in the group II mice was signiﬁ-
cantly less 49.6%, compared to the normal value (Figure 4).
However, treatment with BT, TF, and Omez for 3 days
augmented it by 90.2%, 68.9%, and 75.4%, respectively,
compared to that of the untreated mice. The result with
the TF treatment was signiﬁcantly diﬀerent from the other
treatments.
3.3.2. BT and TF Augment the Depleted Gastric Mucin Due
to Ulceration. Compared to the normal level, ulceration
reduced the mucin level by 41.9%. Treatment with BT and
TF restored it to normalcy, while the eﬀect of Omez was
marginally less (Figure 5).
3.3.3. BT and TF Increase PGE Synthesis by Augmenting the
Expressions of COX Enzymes. T h ew e s t e r nb l o t so fC O X - 1
and COX-2 expressions in the gastric mucosa of the normal,
ulcerated and drug (BT-, TF- or Omez-) treated mice are
shown in Figure 6. The blot of normal gastric tissues showed
very strong COX-1 expression with a low intensity band for
COX-2. Ulceration depleted (P<0.001) the expressions of
gastric COX-1 and COX-2 by 68% and 79%, respectively,
compared to that in normal mice. Treatment with BT and
TF increased (P<0.001) both COX-1 (3 fold) and COX-2
(8 fold) almost equally, compared to the untreated group.
In contrast, the eﬀect of Omez was much less, increasing
the expressions of COX-1 (28.1%, P<0.05) and COX-2Evidence-Based Complementary and Alternative Medicine 7
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Figure 3: The eﬀect of BT, TF, and Omez on the levels of TBARS,
protein carbonyls, and nonprotein thiol (NP-TSH) in the ulcerated
gastric tissues of mice. Ulceration in the mice was induced by
indomethacin (18mg/kg, p. o.). Treatment was carried out for 3
days with BT (40mg/kg), TF (1mg/kg), and Omez (3.0mg/kg) and
the parameters were determined by spectrophotometry. The values
are mean±S.E.M. of three independent experiments, each with 5
mice per group.
∗P < 0.05,
∗∗P < 0.001, compared to normal
group; τP < 0.05,
†P < 0.01, compared to ulcerated group.
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Figure 4: Depletion of the total antioxidant status (TAS) in mice
plasma due to indomethacin-induced acute gastric ulceration, and
its prevention by BT, TF, and Omez. Ulceration in the mice was
induced by indomethacin (18mg/kg, p. o.). Treatment was carried
out for 3 days with BT (40mg/kg), TF (1mg/kg), and Omez
(3.0mg/kg) and TAS was determined by spectrophotometry. The
values are mean±S.E.M. of three independent experiments, each
with 5 mice per group.
∗P < 0.01, compared to normal group;
∗∗P < 0.001, compared to ulcerated group; τP < 0.05, compared
to Omez-treatment.
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Figure 5: Depletion of mucin level in mice stomachs due to
indomethacin-induced acute gastric ulceration and its prevention
by BT, TF, and Omez. Ulceration in the mice was induced by
indomethacin (18mg/kg, p. o.). Treatment was carried out for 3
days with BT (40mg/kg), TF (1mg/kg), and Omez (3.0mg/kg) and
the gastric mucin was determined by assaying the tissue bound
alcian blue. The values are mean±S.E.M. of three independent
experiments, each with 5 mice per group.
∗P < 0.01, compared
to normal group;
∗∗P < 0.05, τP < 0.01, compared to ulcerated
group.
(80.97%, P<0.001), compared to the untreated group. The
eﬀects of BT and TF were signiﬁcantly diﬀerent from that of
Omez.
The serum PGE level was decreased (70%) on the
3rd day of ulceration, compared to that in normal mice
(Figure 7). Treatment with BT, TF, and Omez increased it
by 89.8%, 143.2%, and 70.2%, respectively, the eﬀect of
TF being signiﬁcantly better than that of Omez and BT.
Ulceration also reduced (71%) the mucosal PGE, compared
to that in normal mice. Treatment with BT, TF, and Omez
increased the mucosal PGE by 157.7%, 163.1%, and 131.1%,
respectively, compared to that in the ulcerated mice.
4. Discussion
The concept of gastric ulcer management is changing
fast. Besides uncontrolled acid secretion, damage to the
mucosal defense is also believed to be responsible for the
disease. Understanding the role of factors, contributing to
the mucosal defense might lead to the designing of new
antiulcer drugs. Therefore, we evaluated the healing eﬃcacy
of the common dietary factor, BT and its major constituent,
TF against the indomethacin-mediated gastric ulceration in
mice, and assessed their role in augmenting the mucosal
defense.
Our macroscopic and histopathological results showed
marked gastric mucosal damage in mice, on the 3rd day
after indomethacin administration. This led to elongated
haemorrhagic lesions, conﬁned to the glandular portion,8 Evidence-Based Complementary and Alternative Medicine
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Ulceration in the mice was induced by indomethacin (18mg/kg,
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with highest subjective ulcer-scoring. The partial natural
healing observed in the untreated control mice revealed that
the ulceration was acute. However, the natural healing was
much slower compared to that observed in the mice treated
with the test samples. Both BT and TF showed impressive
mucosal healing, TF being more potent than BT. Under
an optimized three-day treatment regime, BT (40mg/kg),
TF (1mg/kg), and Omez (3mg/kg) produced similar ulcer
healing.
Amongst various factors, oxidative stress (OS) has
been implicated for the induction and pathogenesis of
the indomethacin-mediated gastroduodenal injury [36, 37].
Extensive research has proved that antioxidants might be
eﬀectivenotonlyinprotectingagainstgastricmucosalinjury,
but also inhibiting progression of gastric ulcer. Our results
showed increased accumulation of TBARS and protein
carbonyls along with depletion of NP-TSH in the gastric
tissues, after the indomethacin administration. These were
consistent with the earlier reports on the indomethacin-
induced gastropathy [38, 39]. The induced lipid perox-
idation might cause increased glutathione consumption.
The sulphydryl compounds help in recycling endogenous
antioxidant vitamins, thereby, preventing lipid peroxidation.
More importantly, they also protect mucus by preventing
rupture of the disulﬁde bridges that join the mucus subunits
andmaintainitsstructuralintegrity.Thedecreaseinendoge-
nous thiol (glutathione) in ethanol-induced gastric injury
and its role in mucosal protection has been demonstrated
earlier [39]. Both BT and TF provided nearly similar and
signiﬁcant suppression of the oxidative damages to the
biomacromolecules, compared to that observed in natural
recovery. This might decrease the ulcer progression and
promote healing of gastric lesions induced by acute intake
of indomethacin.
Compared to the individual oxidative markers, assay
of the plasma TAS level provides a better index of the
body’s total systemic antioxidant defense comprising of the
enzymes, such as superoxide dismutase and the selenium-
containing glutathione peroxidase as well as nonenzymic
antioxidants (radical scavengers and chelating agents), and
their synergistic interaction [40]. Our results on the reduced
plasma TAS level of the indomethacin-administered mice
revealed severe oxidative stress. The test samples improved
the parameter markedly, TF being signiﬁcantly more potent
than BT and Omez.
Depletionofgastricmucosalmucinlevelalsocontributes
to the NSAID-mediated gastropathy. Maintenance of mucus
production may provide partial but signiﬁcant protection
against reactive oxygen metabolites. Our results revealed
that stomach ulceration reduced the gastric mucin content.
This might reduce the ability of the mucosal membrane to
protect the mucosa from physical damage and back diﬀusion
of hydrogen ions [41], and hinder epithelial recovery.
Treatment with BT, TF, and Omez signiﬁcantly accelerated
ulcer healing, which was associated with an increase in the
mucin content of the gastric mucosa. Amongst the test
samples, BT and TF, but not Omez, restored the mucin level
to normalcy.
TheNSAIDsexertboththeirtherapeuticandtoxiceﬀects
mainly by decreasing the levels of circulating PGE at the gas-
tricmucosaviainhibition oftheCOXisozymes. Thereduced
level of PGs is known to cause gastric ulceration and also
exacerbate preexisting gastric ulcers in rodents and humans
[3, 42]. PGs stimulate mucus and bicarbonate secretion as
well as mucosal blood ﬂow, and induce angiogenesis [43].
All these factors contribute to accelerated ulcer healing. Our
immunoblots revealed reduced expressions of COX-1 and
COX-2 at peak ulceration, associated with reduced synthesis
of serum and mucosal PGE. Treatment with BT and TF
increased the expressions of both the enzymes, the eﬀect
beingmorepredominantonCOX-2.Omezshowedlesseﬀect
on these enzymes. The test samples augmented the serum
and mucosal PGE that correlated well with their respective
abilities to regulate the expressions of the COX isoforms.
The enhanced PG synthesis by BT and TF might stimulate
the EP4 receptor-mediated mucin synthesis [44] and inhibit
the neutrophil-mediated free radicals generation [45]. In
separate experiments, we did not observe any antisecretory
property of BT and TF. The mechanism of the healing action
of BT and TF against the indomethacin-mediated gastric
ulceration can be summarized as shown in Figure 8.
The tea decoction is a complex mixture of products com-
prisingofagroupofbiopolymers,theaﬂavins,andthewater-
soluble thearubigins [27]. Hence, we did not attempt to
analyze the tea decoctions completely. However, our HPTLC
and HPLC analyses revealed caﬀeine (70%), theaﬂavins
(18%), and catechins (10%) as the major components. Of
these, caﬀeine is suggested to aggravate an existing ulcer
by stimulating acid secretion. However, the stimulation of
stomach acid cannot be attributed solely to caﬀeine [46].
Earlier, the tea catechins have been reported to prevent andEvidence-Based Complementary and Alternative Medicine 9
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Figure 7: Comparative ability of BT, TF, and Omez in regulating the PGE synthesis in acute gastric ulcerated mice. The PGE levels were
measured using ELISA. (a) The serum PGE level. (b) The tissue PGE level. The values are mean±S.E.M. of three independent experiments,
each with 5 mice per group.
∗P < 0.001, compared to normal group;
∗∗P < 0.001, compared to ulcerated group; τP < 0.01, compared to
Omez-treatment;
†P < 0.05, compared to BT-treatment.
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Figure 8: Schematic representation of the mechanism of the ulcer-healing action of BT and TF.
heal gastric ulcers caused by several ulcerogens [18, 19].
However, our results clearly demonstrated that TF could
account for almost the entire healing activity of BT. The
catechins might have a synergistic eﬀect in the healing action
of BT against indomethacin-induced gastric ulceration in
mice. The other water soluble compounds of BT including
the thearubigins of undeﬁned chemical structures were not
included for the studies, since these were envisaged to be too
polar for membrane penetration.
5. Conclusions
Overall, despite the purported gastrotoxicity of BT,
our results clearly revealed its healing ability against
indomethacin-induced stomach ulceration and established
TF as the active principle. The results are consistent with
the anti-inﬂammatory property of TF [47]. Based on the
availableevidence,thetherapeuticeﬀectofthesetestsamples
could be related to their antioxidant, mucin-protecting, and
PGE-enhancing properties.10 Evidence-Based Complementary and Alternative Medicine
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